logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Multi-Country Validation of SAMBA - A Novel Molecular Point-of- Care Test for HIV-1 Detection in Resource-Limited Setting

Ondiek J, Namukaya Z, Mtapuri-Zinyowera S, Balkan S, Elbireer A, Ushiro Lumb I, Kiyaga C, Goel N, Ritchie AV, Ncube P, Omuomu K, Ndiege K, Kekitiinwa AR, Mangwanya D, Fowler MG, Nadala L, Lee HH
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Early diagnosis of HIV-1 infection and the prompt initiation of antiretroviral therapy are critical to achieving a reduction in the morbidity and mortality of infected infants. The SAMBA HIV-1 Qual Whole Blood Test was developed specifically for early infant diagnosis and prevention of mother-to-child transmission programs implemented at the point-of-care in resource-limited settings.

Countries

Kenya Uganda Zimbabwe

Subject Area

diagnosticsHIV/AIDSfilovirus

Languages

English
DOI
10.1097/QAI.0000000000001476
Published Date
09 Jun 2017
PubMed ID
28604503
Journal
Journal of Acquired Immune Deficiency Syndromes (1999)
Volume | Issue | Pages
Volume 76, Issue 2
Issue Date
2017-10-01
Dimensions Badge